# Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 Diabetes

> **NCT02544321** · PHASE2 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 108 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Bromocriptine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02544321
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2019-06
- **Final completion:** 2019-06
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2021-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02544321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02544321, "Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02544321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*